| Lindy Hinckley, | |
|
314 S Main St, Chamberlain, SD 57325-1521 | |
| (605) 271-1081 | |
| Not Available |
| Full Name | Lindy Hinckley |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 314 S Main St, Chamberlain, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013654466 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 11547 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lindy Hinckley, 409 Kenyon Rd Ste C, Fort Dodge, IA 50501-5718 Ph: (515) 573-3138 | Lindy Hinckley, 314 S Main St, Chamberlain, SD 57325-1521 Ph: (605) 271-1081 |
News Archive
Global nanotechnology company pSivida Limited has announced that it's UK manufacturing partner, Atomising Systems Ltd ("ASL"), has reached a key milestone in the manufacture of BrachySil, its lead product, by completing construction of a state of the art dedicated cleanroom facility to GMP specifications at its Sheffield plant in the United Kingdom. ASL is a world leader in high temperature atomising technology.
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein.
Alkermes plc today announced positive topline results from a phase 1/2 study of ALKS 5461, a novel drug compound for major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for clinical depression.
HemoShear LLC, a biotechnology research company and leading developer of human cell-based surrogate systems for discovery and assessment of new drug compounds, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it patent no. 7,811,782 entitled "Use of An In Vitro Hemodynamic Endothelial/Smooth Muscle Cell Co-Culture Model to Identify New Therapeutic Targets for Vascular Disease."
Researchers at Tufts Medical Center and collaborators discovered a new biological pathway for advanced age-related macular degeneration that implicates a role of the hepatic lipase gene, LIPC. This discovery will improve understanding of the disease by providing researchers another developmental pathway to explore for prevention and treatment.
› Verified 4 days ago
Dr. Karen Sue Guest, PH.D. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 108 E Clemmer Ave, Chamberlain, SD 57325 Phone: 605-734-6347 Fax: 605-734-0577 |